Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,641 to 1,660 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A 2x folic acid treatment affects epigenetics and dendritic spine densities in SHSY5Y cells. | Biochem Biophys Rep | 2019 | 31467993 | PubTator, text mining | PubMed |
| Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies. | J Oncol | 2019 | 31467542 | PubTator, text mining | PubMed |
| Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network. | Front Immunol | 2019 | 31456805 | PubTator, text mining | PubMed |
| Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events. | ESMO Open | 2019 | 31423333 | PubTator, text mining | PubMed |
| CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine. | Front Immunol | 2019 | 31417570 | PubTator, text mining | PubMed |
| Tripartite motif proteins: an emerging antiviral protein family. | Future Virol | 2019 | 31406497 | PubTator, text mining | PubMed |
| ERβ-selective agonist alleviates inflammation in a multiple sclerosis model via regulation of MHC II in microglia. | Am J Transl Res | 2019 | 31396345 | PubTator, text mining | PubMed |
| HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target. | Cancers (Basel) | 2019 | 31394860 | PubTator, text mining | PubMed |
| High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells. | Cancers (Basel) | 2019 | 31394808 | PubTator, text mining | PubMed |
| Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma. | Cancers (Basel) | 2019 | 31382450 | PubTator, text mining | PubMed |
| Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma. | Cancer Immunol Res | 2019 | 31371317 | PubTator, text mining | PubMed |
| Cytokine Expression Patterns and Single Nucleotide Polymorphisms (SNPs) in Patients with Chronic Borreliosis. | Antibiotics (Basel) | 2019 | 31366164 | PubTator, text mining | PubMed |
| Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies. | Cancers (Basel) | 2019 | 31362369 | PubTator, text mining | PubMed |
| A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44. | Nat Immunol | 2019 | 31358998 | PubTator, text mining | PubMed |
| Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism. | Transl Psychiatry | 2019 | 31358727 | PubTator, text mining | PubMed |
| Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma. | Surg Pathol Clin | 2019 | 31352982 | PubTator, text mining | PubMed |
| Alternative splicing regulates stochastic NLRP3 activity. | Nat Commun | 2019 | 31324763 | PubTator, text mining | PubMed |
| Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility. | Mol Cell Endocrinol | 2019 | 31319097 | PubTator, text mining | PubMed |
| Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray. | Biomolecules | 2019 | 31311202 | PubTator, text mining | PubMed |
| Immunology of Mycobacterium tuberculosis Infections. | Microbiol Spectr | 2019 | 31298204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=83